Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jaguar Health (JAGX) Assets (2016 - 2025)

Jaguar Health (JAGX) has disclosed Assets for 11 consecutive years, with $49.5 million as the latest value for Q3 2025.

  • On a quarterly basis, Assets fell 15.38% to $49.5 million in Q3 2025 year-over-year; TTM through Sep 2025 was $49.5 million, a 15.38% decrease, with the full-year FY2024 number at $53.4 million, up 5.24% from a year prior.
  • Assets was $49.5 million for Q3 2025 at Jaguar Health, up from $48.3 million in the prior quarter.
  • In the past five years, Assets ranged from a high of $69.5 million in Q2 2021 to a low of $45.4 million in Q3 2023.
  • A 5-year average of $54.5 million and a median of $52.9 million in 2022 define the central range for Assets.
  • Peak YoY movement for Assets: skyrocketed 106.49% in 2021, then fell 28.26% in 2022.
  • Jaguar Health's Assets stood at $53.3 million in 2021, then dropped by 10.91% to $47.5 million in 2022, then grew by 6.98% to $50.8 million in 2023, then grew by 5.24% to $53.4 million in 2024, then decreased by 7.4% to $49.5 million in 2025.
  • Per Business Quant, the three most recent readings for JAGX's Assets are $49.5 million (Q3 2025), $48.3 million (Q2 2025), and $51.5 million (Q1 2025).